Home › Research › Tau biomarkers
Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia
Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O.. Archives of general psychiatry, 2012-01-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Context Early detection of prodromal Alzheimer disease (AD) is important because new disease-modifying therapies are most likely to be effective when initiated during the early stages of disease. Objectives To assess the ability of the cerebrospinal fluid (CSF) biomarkers total tau (T-tau), phosphorylated tau (P-tau), and β-amyloid 1-42 (Aβ42) to predict future development of AD dementia within 9.2 years in patients with mild cognitive impairment (MCI) and to compare CSF biomarkers between early and late converters to AD. Design A clinical study with a median follow-up of 9.2 years (range, 4.1-11.8 years).
What this study adds
Evidence grade: Low
The record lists 137 participants. This study took spinal-fluid samples from 137 people who already had mild cognitive impairment and followed them for a median of 9.2 years (range 4.1–11.8) to see who developed Alzheimer dementia. Reported effect size: 53.7%; 15.7%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Buchhave, P., Minthon, L., Zetterberg, H., Wallin, A. K., Blennow, K., & Hansson, O. (2012). Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Archives of general psychiatry. https://doi.org/10.1001/archgenpsychiatry.2011.155
Vancouver
Buchhave P, Minthon L, Zetterberg H, Wallin AK, Blennow K, Hansson O. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia. Archives of general psychiatry. 2012. doi:10.1001/archgenpsychiatry.2011.155. PMID: 22213792.
BibTeX
@article{buchhave2012-22213792,
author = {Buchhave, P. and Minthon, L. and Zetterberg, H. and Wallin, A. K. and Blennow, K. and Hansson, O.},
title = {{Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia}},
journal = {Archives of general psychiatry},
year = {2012},
doi = {10.1001/archgenpsychiatry.2011.155},
pmid = {22213792},
url = {https://doi.org/10.1001/archgenpsychiatry.2011.155}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Objectives To assess the ability of the cerebrospinal fluid (CSF) biomarkers total tau (T-tau), phosphorylated tau (P-tau), and β-amyloid 1-42 (Aβ42) to predict future development of AD dementia within 9.2 years in patients with mild cognitive impairment (MCI) and to compare CSF biomarkers between early and late converters to AD.
- Design A clinical study with a median follow-up of 9.2 years (range, 4.1-11.8 years).
- Patients A total of 137 patients with MCI who underwent lumbar puncture at baseline.
- MAIN OUTCOME MEASURE Conversion to AD dementia.
Why it matters
This study took spinal-fluid samples from 137 people who already had mild cognitive impairment and followed them for a median of 9.2 years (range 4.1–11.8) to see who developed Alzheimer dementia. Its title reports that one amyloid marker (β-amyloid 1-42) was already fully changed 5 to 10 years before dementia began, while tau markers were not. The summary held here ends before the results, so no accuracy figures are available, and as an observational study it cannot show that amyloid causes dementia or that any treatment would prevent it.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants137
- Effect size53.7%; 15.7%
- Evidence strengthLow
How this study scored 56/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of general psychiatry) |
| Journal's citation record | 4 / 4 | Archives of General Psychiatry: journal h-index 543 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2012 — within 20 year(s) of the newest study here |
| Sample size | 2 / 4 | 137 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 664 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 41.5 citations a year over 16 year(s) since 2012 |
| Impact for its field and year | 6 / 6 | Cited 49.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 50 other studies in this library |
| Still being cited | 3 / 4 | Cited 98 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Peder Buchhave: h-index 12 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Skåne University Hospital: institution h-index 625 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 22213792) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 56 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 24.
Later studies that cite this one
50 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.